Ellen C.M. Mommers
- Oncology top 5%
- Cancer Research top 2%
- Molecular Biology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Elsken van der WallP. J. van DiestChris J.L.M. MeijerGregg L. SemenzaHaining ZhongHerbert M. PinedoMartin D. AbeloffColleen F. Hanrahan
- Topics
- Breast Lesions and Carcinomas (7 papers)Breast Cancer Treatment Studies (5 papers)Cancer-related Molecular Pathways (5 papers)
- Journals
- Journal of Clinical OncologyJNCI Journal of the National Cancer InstituteThe Lancet Oncology
- Partner nations
- NetherlandsCanadaGermany
In The Last Decade
Ellen C.M. Mommers
19 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 815
- Cancer Research 805
- Molecular Biology 700
- Radiology, Nuclear Medicine and Imaging 341
- Pathology and Forensic Medicine 240
Countries citing papers authored by Ellen C.M. Mommers
This map shows the geographic impact of Ellen C.M. Mommers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen C.M. Mommers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen C.M. Mommers more than expected).
Fields of papers citing papers by Ellen C.M. Mommers
This network shows the impact of papers produced by Ellen C.M. Mommers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen C.M. Mommers. The network helps show where Ellen C.M. Mommers may publish in the future.
Co-authorship network of co-authors of Ellen C.M. Mommers
This figure shows the co-authorship network connecting the top 25 collaborators of Ellen C.M. Mommers. A scholar is included among the top collaborators of Ellen C.M. Mommers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen C.M. Mommers. Ellen C.M. Mommers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion studybreakdown → | 400 |
| 2 | 53 | |
| 3 | 10 | |
| 4 | 160 | |
| 5 | 9 | |
| 6 | 16 | |
| 7 | Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesisbreakdown → | 508 |
| 8 | 33 | |
| 9 | 114 | |
| 10 | 43 | |
| 11 | 123 | |
| 12 | 18 | |
| 13 | 23 | |
| 14 | 62 | |
| 15 | 3 | |
| 16 | 39 | |
| 17 | 43 | |
| 18 | 43 | |
| 19 | 91 |
About Ellen C.M. Mommers
Ellen C.M. Mommers is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 19 papers that have together received 1.8k indexed citations. Recurring topics across this work include Breast Lesions and Carcinomas (7 papers), Breast Cancer Treatment Studies (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Cancer Research (805 citations), Oncology (815 citations) and Radiology, Nuclear Medicine and Imaging (341 citations). Ellen C.M. Mommers has collaborated with scholars based in Netherlands, Canada and Germany. Frequent co-authors include Elsken van der Wall, P. J. van Diest, Chris J.L.M. Meijer, P. J. van Diest, Gregg L. Semenza, Haining Zhong, Herbert M. Pinedo, Martin D. Abeloff, Colleen F. Hanrahan and Reinhard Bos. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.